Sionna Therapeutics, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Sionna Therapeutics, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($20.28M) | Nov 5, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($18.07M) | Aug 11, 2025 |
| Q3 | 2025 | Jun 30, 2025 | ($18.07M) | Nov 5, 2025 |
| Q3 | 2025 | Mar 31, 2025 | ($16.48M) | Nov 5, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($16.48M) | May 12, 2025 |
| Q2 | 2025 | Mar 31, 2025 | ($16.48M) | Aug 11, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($25.44M) | Nov 5, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($8.55M) | Aug 11, 2025 |
| Q3 | 2025 | Jun 30, 2024 | ($8.55M) | Nov 5, 2025 |
| Q2 | 2025 | Mar 31, 2024 | ($11.85M) | Aug 11, 2025 |
| Q3 | 2025 | Mar 31, 2024 | ($11.85M) | Nov 5, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($11.85M) | May 12, 2025 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($23.81M) | Nov 5, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($21.91M) | Aug 11, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($19.66M) | May 12, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($27.98M) | Nov 5, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($11.29M) | Aug 11, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($13.15M) | May 12, 2025 |